Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MiniMed Group Inc. Common Stock (MMED) vs Okta, Inc. (OKTA) Price & Performance

MiniMed Group Inc. Common StockTrade
Okta, Inc.Trade

Price performance (Past 24H)

Key statistics

MiniMed Group Inc. Common Stock vs Okta, Inc. — how do they compare? MiniMed Group Inc. Common Stock trades at $19.71 (market cap $5.57B), while Okta, Inc. trades at $232.13 (market cap $38.50B). The key difference: Okta, Inc. is far larger — about 6.9× MiniMed Group Inc. Common Stock's market cap, and Okta, Inc. is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 1 Days and Okta, Inc. for 44 Days on average.

MMEDOKTA
Market Cap
$5.57B$38.50B
Volume
23,336,0732,479,621
Sector
HealthTechnology
52-Week High
$23.84$220.21
52-Week Low
$10.80$62.93
Typical Hold Time
1 Days44 Days
Enterprise Value
$5.37B$36.25B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MiniMed Group Inc. Common Stock

No Aura AI signal available yet.

Okta, Inc.

OKTA trades at $220.21, up 1.01% on the day, with a bullish technical signal from moving averages and strong analyst support (73.58% buy ratings). The company reported a net income of $28 million in 2025, marking a return to profitability after losses in prior years, with revenue growing to $2.61 billion. Recent news highlights its AI agent security initiatives, including the Blueprint Alliance unveiled at Oktane 2026.

The outlook is positive due to earnings beats, AI-driven growth potential, and improving cash flow, but risks include high valuation multiples (P/E of 132.66) and competitive pressures in cybersecurity. The stock trades above the consensus price target of $201.30, suggesting near-term consolidation may occur despite long-term growth prospects.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MMED

No sentiment data available yet.

OKTA
43% Buy57% Sell
Avg holding period · 44 Days

About MiniMed Group Inc. Common Stock

MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.

Read more on MMED →

About Okta, Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

Read more on OKTA →